Nutrinnovator Holdings PLC
23 June 2005
Nutrinnovator Holdings PLC
23 June 2005
NUTRINNOVATOR HOLDINGS plc
(the 'Company')
CAPITAL RE-ORGANISATION, PLACING AND ADMISSION TO TRADING
Further to its announcement of 20 June 2005, the Company announces the
successful completion of its Proposals in connection with the acquisition of
Provexis Limited and consequently that 249,628,324 new ordinary shares of 1p
each will be admitted to trading, and dealings will commence in the new enlarged
share capital of the Company on AIM at 8.00 am today ('Admission').
The Company's change of name to Provexis plc which was approved by its
shareholders at its Extraordinary General Meeting held on 20 June 2005 is
conditional upon Admission, and therefore dealings will commence in the name of
Provexis plc, AIM:PXS.L, at 8.00 am tomorrow, 24 June 2005.
For further information please contact:
Nutrinnovator Holdings plc
Stephen Moon, Managing Director 020 8392 6631
Oriel Securities Limited
Andrew Edwards 020 7710 7600
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.